A role for antiangiogenic therapy in breast cancer (Q35603882)

9 August 2017

1 reference

title

A role for antiangiogenic therapy in breast cancer (English)

1 reference

9 August 2017

main subject

angiogenesis inhibitor

1 reference

Marsha A Moses

1 reference

9 August 2017

Jay Harper

1 reference

9 August 2017

Cecilia A Fernández

series ordinal

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

published in

Current Oncology Reports

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

9 August 2017

page(s)

42-48

1 reference

Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester

9 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-996-0008-6

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-996-0008-6

Inhibition of angiogenesis by tissue inhibitor of metalloproteinase

21 January 2018

1 reference

12 December 2020

Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors.

1 reference

12 December 2020

Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women

1 reference

12 December 2020

Successful treatment of infantile hemangiomas with interferon-alpha-2b

1 reference

12 December 2020

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

1 reference

12 December 2020

Tissue inhibitor of metalloproteinases‐2 inhibits bFGF‐induced human microvascular endothelial cell proliferation

1 reference

12 December 2020

Cardiac dysfunction in the trastuzumab clinical trials experience

1 reference

12 December 2020

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

12 December 2020

Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human p

1 reference

12 December 2020

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer

1 reference

12 December 2020

Angiogenesis and breast cancer

1 reference

12 December 2020

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17

1 reference

12 December 2020

The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma

1 reference

12 December 2020

Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients

1 reference

12 December 2020

Vascular endothelial groth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatininase a activation and cell proliferation

1 reference

12 December 2020

Angiogenic molecules and mechanisms in breast cancer

1 reference

12 December 2020

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Antiangiogenesis drug promising for metastatic colorectal cancer

1 reference

12 December 2020

Interferon alpha therapy of haemangiomas in newborns and infants

1 reference

12 December 2020

WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis

1 reference

12 December 2020

Identification of an Inhibitor of Neovascularization from Cartilage

1 reference

12 December 2020

Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy

1 reference

12 December 2020

Tetradecanoyl phorbol acetate stimulates latent collagenase production by cultured human endothelial cells

1 reference

12 December 2020

Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells

1 reference

12 December 2020

Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model

1 reference

12 December 2020

In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.

1 reference

12 December 2020

Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells

1 reference

12 December 2020

Tumor-promoting phorbol esters induce angiogenesis in vitro

1 reference

12 December 2020

Vascular Endothelial Growth Factor Increases Release of Gelatinase A and Decreases Release of Tissue Inhibitor of Metalloproteinases by Microvascular Endothelial Cellsin Vitro

1 reference

12 December 2020

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

12 December 2020

Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3

1 reference

12 December 2020

Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer

1 reference

12 December 2020

Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.

1 reference

12 December 2020

Angiogenesis as a target for breast cancer therapy

1 reference

12 December 2020

Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinoma in a transgenic mouse model

1 reference

12 December 2020

HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis

1 reference

12 December 2020

Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance

1 reference

12 December 2020

Plasminogen activator and collagenase production by cultured capillary endothelial cells

1 reference

12 December 2020

Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis.

1 reference

12 December 2020

Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer

1 reference

12 December 2020

Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.

1 reference

12 December 2020

Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer

1 reference

12 December 2020

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

12 December 2020

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

12 December 2020

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

12 December 2020

Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells

1 reference

12 December 2020

Interstitial collagenase is required for angiogenesis in vitro

1 reference

12 December 2020

The influence of angiogenesis research on management of patients with breast cancer

1 reference

12 December 2020

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

1 reference

12 December 2020

Increased incidence of matrix metalloproteinases in urine of cancer patients

1 reference

12 December 2020

Radiation therapy to a primary tumor accelerates metastatic growth in mice

1 reference

12 December 2020

Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel

1 reference

12 December 2020

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

12 December 2020

The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL.

1 reference

12 December 2020

Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors

1 reference

12 December 2020

Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.

1 reference

12 December 2020

10.1007/S11912-996-0008-6

Identifiers

DOI

1 reference

9 August 2017

1 reference